BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2000
View Archived Issues
Screening method based on spectral data offered by NIH for licensing
Read More
NIH offers molecules that influence pathogen resistance for licensing
Read More
NIH offers M-CSF antagonist for licensing as antiviral therapy
Read More
NIH offers S-nitrosoglutathione for licensing as AIDS therapy
Read More
NIH licensing opportunity: hematopoietic enhancement using prolactin
Read More
Palatin Technologies awarded phase I SBIR grant for pain management therapies
Read More
Flamel Technologies seeks approval of Genvir herpes therapy in France
Read More
GenVec begins phase II trials of BioByPass in PVD
Read More
Teverelix shows promise in first-dose-in-humans study
Read More
Further notice of serious hypersensitivity reactions associated with Ziagen issued by EMEA
Read More
Innogenetics commences phase I trial of therapeutic hepatitis C vaccine
Read More
Progenics and Pharmacopeia establish new antiviral drug discovery collaboration
Read More
Merz and Lundbeck to develop and market memantine for various CNS indications
Read More
Salix receives milestone payment from Shire for balsalazide
Read More
Phytera and Novelos Therapeutics enter collaborative agreement for novel cancer immunotherapy
Read More
QLT and Ciba Vision seek expanded labeling for Visudyne
Read More
Lundbeck's siramesine enters phase II development
Read More
New compounds interacting with muscarinic M3 receptor useful for urinary disorders
Read More
Analgesic agents under development at Banyu
Read More
DHEA evaluated for depression, AD and adrenal insufficiency
Read More
Kyowa Hakko claims new series of NF-kappaB inhibitors
Read More
Antifungal agents under study at Takeda
Read More
New series under development at Pharmacia for treatment of cancer
Read More